New Insights into Opioid Treatment Program Retention Rates in Medicaid Patients Recent research highlights significant disparities in Medicaid patient retention rates across opioid treatment programs, emphasizing the need for quality improvements.

New Insights into Opioid Treatment Program Retention Rates in Medicaid Patients #United_States #Research_Triangle_Park #RTI_International #Opioid_Treatment #Medicaid_Patients

Innovative Grant Targets Opioid Reduction in Burn Treatment at UT Health San Antonio A new grant at UT Health San Antonio aims to reduce opioid requirements for burn patients by 90%, improving healing and minimizing scars.

Innovative Grant Targets Opioid Reduction in Burn Treatment at UT Health San Antonio #United_States #San_Antonio #Opioid_Treatment #Trauma_Research #UT_Health

Armor Health Enhances Opioid Treatment Program to Combat Addiction in Franklin County Armor Health expands its Medication-Assisted Treatment programs in Franklin County, Ohio, aiming to decrease opioid addiction and recidivism.

Armor Health Enhances Opioid Treatment Program to Combat Addiction in Franklin County #United_States #Columbus #SUBLOCADE #Opioid_Treatment #Armor_Health

APhA's Legislative Triumph Expands Pharmacists' Role in Buprenorphine Prescribing and Opioid Treatment The American Pharmacists Association celebrates a legislative success allowing pharmacists to prescribe buprenorphine following specialized training, crucial in battling opioid crisis.

APhA's Legislative Triumph Expands Pharmacists' Role in Buprenorphine Prescribing and Opioid Treatment #United_States #Washington #APhA #Opioid_Treatment #Buprenorphine

Indivior Finalizes Settlement with U.S. Department of Justice to Move Forward Indivior PLC has officially settled a legacy matter with the U.S. Department of Justice by paying $295 million, marking a pivotal change for the company.

Indivior Finalizes Settlement with U.S. Department of Justice to Move Forward #United_States #Richmond #Indivior #Opioid_Treatment #Department_of_Justice

Dekalb County's Innovative Program Tackles Opioid Crisis in Jails Dekalb County and Armor Health have launched a groundbreaking Opioid Treatment Program in jail, enhancing recovery access for inmates.

Dekalb County's Innovative Program Tackles Opioid Crisis in Jails #United_States #Decatur #Opioid_Treatment #DeKalb_County #Armor_Health

New Study Reveals Neurostimulation Device Could Combat Addiction by Reducing Opioid and Stimulant Use A recent clinical study indicates that NET Recovery's neurostimulation device may reduce both opioid and stimulant use, providing hope in addiction treatment.

New Study Reveals Neurostimulation Device Could Combat Addiction by Reducing Opioid and Stimulant Use #United_States #Costa_Mesa #Opioid_Treatment #NET_Recovery #NET_Device

Indivior Announces Strategic Shift to U.S. Domiciliation for Growth and Innovation Indivior PLC has proposed a significant change in its corporate structure, transitioning its domicile from the U.K. to the U.S. to enhance market presence.

Indivior Announces Strategic Shift to U.S. Domiciliation for Growth and Innovation #United_States #Richmond #pharmaceuticals #Indivior #Opioid_Treatment

Indivior Completes Cancellation of Secondary Listing on London Stock Exchange Indivior PLC has announced the successful cancellation of its secondary listing on the London Stock Exchange while maintaining its primary listing on Nasdaq. Learn more about this strategic move.

Indivior Completes Cancellation of Secondary Listing on London Stock Exchange #United_Kingdom #Richmond #Opioid_Treatment #Indivior_PLC #Nasdaq_Stock_Exchange

Indivior Grows Its Market Presence with Inclusion in Russell 2000® Index Indivior PLC has officially been added to the U.S. Russell 2000® Index, aligning its capital market presence with its expanding U.S. operations.

Indivior Grows Its Market Presence with Inclusion in Russell 2000® Index #United_States #Richmond #Russell_2000 #Indivior #Opioid_Treatment

Indivior Appoints Patrick Barry as Chief Commercial Officer, Strengthening Leadership in Opioid Treatment Indivior PLC has appointed Patrick Barry as Chief Commercial Officer to enhance its growth strategy in treating opioid use disorder, effective June 2.

Indivior Appoints Patrick Barry as Chief Commercial Officer, Strengthening Leadership in Opioid Treatment #United_States #Richmond #Opioid_Treatment #Indivior_PLC #Patrick_Barry

Mobile Medical Clinics Funded by Opioid Settlement Address Treatment Gaps and Community Needs Government-funded mobile medical clinics are revolutionizing opioid treatment access, making life-saving care available in underserved communities.

Mobile Medical Clinics Funded by Opioid Settlement Address Treatment Gaps and Community Needs #USA #Phoenix #Opioid_Treatment #Mobile_Clinics #Quality_Vans

Indivior Reports Financial Results for FY and Q4 2024: Key Insights and Future Outlook Indivior PLC has released its financial results for the fiscal year and the fourth quarter of 2024, showcasing its commitment to combating substance use disorders.

Indivior Reports Financial Results for FY and Q4 2024: Key Insights and Future Outlook #United_Kingdom #pharmaceuticals #Indivior #Opioid_Treatment #Slough